JUUL unleashed the youth vaping epidemic with kid-friendly flavors & deceptive promotion. Now, the Trump Admin is giving Big Tobacco the green light to poison kids while lining their pockets.
I call on FDA Commissioner Makary to protect our kids & reverse this shameful decision.
Congress Member Profile|U.S. Senator|Democrat|Illinois
Richard J. Durbin
Source: Wikipedia • View full (CC BY-SA)
SoupScoreanalysis-first civic rating · view full breakdown
Loading…
Voting Record — 789
Yes34%
No63%
Present0%
Not Voting3%
Party align93%
Cross-party6%
SoupScore
District Map
Senate District (Statewide)
U.S. Census Bureau boundary data.
Social & Web
External Resources
Richard J. Durbin
U.S. SenatorDemocratIllinois
SoupScore
Richard J.'s ATmosphere Activity
20 recent posts · 126 sponsored · 340 cosponsored
Recent ATmosphere posts, sponsorships, and cosponsorships.
The Epstein files must come to light.
So, we provided an amendment to an appropriations bill to require Attorney General Bondi retain, preserve, and compile the Epstein files and submit a report to Congress.
It passed unanimously.
Reposted bySenator Dick Durbin
BREAKING: Sens. DURBIN, VAN HOLLEN call on Attorney General Bondi to immediately release the Epstein files.
The Illinois agricultural sector is vital to our state’s economy.
This week, I sat down with members of the Illinois Corn Growers to discuss their federal policy priorities.
Thanks to fed funded research, Illinois is #1 in the nation and 5th in the world for growing soybeans.
But Donald Trump’s cuts to USAID and USDA is Making China Great in ag research.
This damages the long-term strategy for U.S. farming.
Read more in my op-ed. ⬇️
Today, Chairman Grassley blocked Democratic members from discussing the controversial records of nominees like Emil Bove and Jeanine Pirro, shut down debate, and forced votes for no apparent reason.
My question is this: what are my Senate Republican colleagues trying to hide?
When I was Chair, I only limited debate when Republicans invoked Senate rules to shut down Committee meetings, and after Committee members were given ample opportunities to voice their concerns about nominees on the agenda.
And today, he cut off debate time on Mr. Bove’s nomination before turning to his vote, as well as nine other nominations, including Ms. Pirro’s.
Chairman Grassley claimed that he was following Committee precedent.
This is simply untrue.
Given Mr. Reuveni’s credible allegations against Mr. Bove, which, if true, clearly disqualify him for a lifetime appointment to the federal bench, I called for the Committee to hear from Mr. Reuveni, under oath, before we voted on Mr. Bove’s nomination.
But Chairman Grassley denied that request.
I asked Mr. Reuveni whether he could substantiate his claims, and in response, he provided text messages, email exchanges, and other documents corroborating his allegations.
That complaint recounted that Mr. Bove suggested DOJ might need to say "f--- you" to federal courts that issued orders that the Administration opposed.
Additionally, Erez Reuveni, a career Justice Department attorney who defended the first Trump Administration’s immigration policies, filed a whistleblower complaint with my office regarding Mr. Bove.
He led the Administration’s effort to strike a corrupt bargain with New York City Mayor Eric Adams and has been trailed by a history of complaints—long predating his affiliation with President Trump—about his temperament, poor judgment, and lack of candor before the court.
Today’s Committee executive business meeting included 10 nominees—among them Emil Bove, nominated for a lifetime appointment on the federal bench.
Mr. Bove belongs nowhere near the federal bench.
Reposted bySenator Dick Durbin
Sen. BOOKER just lambasted Republicans for trying to ram through judicial nominees and break committee rules.
Democrats walked out.
Watch. 🔥
Big Pharma’s newest scheme funnels patients to telehealth companies chosen and paid by drug companies—this can lead to inappropriate prescribing.
My colleagues and I are exposing Big Pharma’s ploy to promote and sell expensive medications, risking inferior patient care.
BREAKING: I just released an investigative report on Big Pharma’s sales scheme to steer patients towards costly medications.
Handpicking telehealth companies to treat Pfizer & Eli Lilly patients creates a potential conflict of interest & raises Rx costs.
We are talking about a LIFETIME appointment to the federal bench. Shameful.
SoupScore Breakdown
Loading analysis metrics…
Voting History789 total votesExpandCollapse
Voting History
789 total votes
Recent roll calls with party-majority context so it is easier to scan how this member tends to vote.
| Date | Bill | Question | Position | Party Maj | Align? | Result |
|---|---|---|---|---|---|---|
| 2025-07-28 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (50-39) |
| 2025-07-28 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (51-45) |
| 2025-07-24 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (50-48) |
| 2025-07-24 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (51-47) |
| 2025-07-24 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (52-46) |
| 2025-07-24 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (52-46) |
| 2025-07-23 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (49-47) |
| 2025-07-23 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (49-47) |
| 2025-07-23 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (48-47) |
| 2025-07-23 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (49-47) |
| 2025-07-23 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (49-47) |
| 2025-07-23 | H.R. 3944 (119th) | Begin consideration | YES | YES | ✓ | Motion to Proceed Agreed to (90-8) |
| 2025-07-23 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (51-47) |
| 2025-07-23 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (52-41) |
| 2025-07-22 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (61-35) |
| 2025-07-22 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (51-46) |
| 2025-07-22 | H.R. 3944 (119th) | End filibuster to begin debate | YES | YES | ✓ | Cloture on the Motion to Proceed Agreed to (91-7, 3/5 majority required) |
| 2025-07-22 | H.R. 3944 (119th) | Begin consideration | NO | NO | ✓ | Motion to Proceed Agreed to (50-48) |
| 2025-07-22 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (50-47) |
| 2025-07-22 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (51-46) |
| 2025-07-22 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (50-47) |
| 2025-07-21 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (44-43) |
| 2025-07-17 | — | End debate | NOT_VOTING | NO | — | Cloture Motion Agreed to (46-36) |
| 2025-07-17 | — | End debate | NOT_VOTING | NO | — | Cloture Motion Agreed to (50-34) |
| 2025-07-17 | — | End debate | NOT_VOTING | NO | — | Cloture Motion Agreed to (57-31) |
| 2025-07-17 | — | End debate | NOT_VOTING | NO | — | Cloture Motion Agreed to (49-40) |
| 2025-07-17 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (49-43) |
| 2025-07-17 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (52-46) |
| 2025-07-17 | H.R. 4 (119th) | Final passage | NO | NO | ✓ | Bill Passed (51-48) |
| 2025-07-17 | H.R. 4 (119th) | Vote on amendment | NO | NO | ✓ | Amendment Agreed to (52-47) |
| 2025-07-17 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (48-51) |
| 2025-07-17 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (48-51) |
| 2025-07-17 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (49-50) |
| 2025-07-17 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (47-51) |
| 2025-07-17 | H.R. 4 (119th) | Kill the motion | NO | NO | ✓ | Motion to Table Agreed to (51-47) |
| 2025-07-16 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (47-50) |
| 2025-07-16 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (46-51) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (47-52) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (47-52) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Send back to committee | YES | YES | ✓ | Motion to Recommit Rejected (48-51) |
| 2025-07-16 | H.R. 4 (119th) | Vote on amendment | YES | YES | ✓ | Amendment Rejected (49-50) |
| 2025-07-15 | H.R. 4 (119th) | Begin consideration | NO | NO | ✓ | Motion to Proceed Agreed to (50-50, Vice President of the United States, voted Yea) |
| 2025-07-15 | H.R. 4 (119th) | Motion to Discharge H.R. 4 | NO | NO | ✓ | Motion to Discharge Agreed to (50-50, Vice President of the United States, voted Yea) |
| 2025-07-15 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (52-47) |
Alignment stats consider only votes where a clear yes/no majority existed for the legislator's party. Cross-party marks divergence where the vote matched the opposite party majority. ↔ indicates cross-party divergence.